bioRxiv Science⌕ Search

Biology subjects

Ozery-Flato, M.

Publications and source records attributed to Ozery-Flato, M..

2 recordsLinked to original sources

A structural antibody benchmark for leakage-aware deep-learning evaluation

Deep-learning methods for antibody structure prediction, antibody-antigen interaction modelling and design are advancing rapidly. However, comparisons across studies remain difficult because training and test sets are often constructed independently, and a temporal cutoff alone does not prevent train-test leakage. We present SABLE (Structural Antibody Benchmark for deep-Learning Evaluation), a versioned structural antibody resource that couples a fixed training collection with a leakage-controlled held-out test set for reproducible machine-learning development and evaluation. SABLE combines 16,511 experimental training entries with 327 manually reviewed test entries and 3,274 high-confidence, patent-derived AlphaFold3 models spanning 476 antigens. Candidate test structures were selected after the AlphaFold3 temporal cutoff and filtered against the training set using antibody and antigen sequence similarity filters. Each test entry records its nearest training set neighbour, allowing users to quantify remaining relatedness and stratify performance by similarity. Versioned releases provide metadata, processed structures, CDR annotations, redundancy labels and model-confidence fields. A Python/PyTorch API and standardised benchmark metrics provide reproducible database access and evaluation code without requiring additional antibody-structure processing.

bioinformatics↗

Characterizing Subpopulations with Better Response to Treatment Using Observational Data - an Epilepsy Case Study

Electronic health records and health insurance claims, providing observational data on millions of patients, offer great opportunities, and challenges, for population health studies. The objective of this study is identifying subpopulations that are likely to benefit from a given treatment using observational data. We refer to these subpopulations as \"better responders\" and focus on characterizing these using linear scores with a limited number of variables. Building upon well-established causal inference techniques for analyzing observational data, we propose two algorithms that generate such scores for identifying better responders, as well as methods for evaluating and comparing these scores. We applied our methodology to a large dataset of ~135,000 epilepsy patients derived from claims data. Out of this sample, 85,000 were used to characterize subpopulations with better response to next-generation (\"Newer\") anti-epileptic drugs (AEDs), compared to an alternative treatment by first-generation (\"Older\") AEDs. The remaining 50,000 epilepsy patients were then used to evaluate our scores. Our results demonstrate the ability of our scores to identify large subpopulations of epilepsy patients with significantly better response to newer AEDs.

epidemiology↗